Schedule 13G ownership disclosure

Sagimet Biosciences Inc

Series A Common Stock, $0.0001 par value per share · CUSIP: 786700104

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • New Enterprise Associates 13, L.P.

    Shares: 0.00 · Class: 0%

  • NEA Partners 13, L.P.

    Shares: 0.00 · Class: 0%

  • NEA 13 GP, LTD

    Shares: 0.00 · Class: 0%

  • Forest Baskett

    Shares: 0.00 · Class: 0%

  • Anthony A. Florence, Jr.

    Shares: 0.00 · Class: 0%

  • Patrick J. Kerins

    Shares: 0.00 · Class: 0%

  • Mohamad H. Makhzoumi

    Shares: 0.00 · Class: 0%

  • Scott D. Sandell

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-25-000364
Form type
SCHEDULE 13G/A
Filer
NEW ENTERPRISE ASSOCIATES 13 LP
CIK
CIK 1452907
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub